PSBs told to monetise investments in arms
New Delhi: The finance ministry has asked public sector banks (PSBs) to look at monetising their investment in subsidiaries by listing them at bourses after further scaling up operations so that they realise good return.
There are about 15 subsidiaries or joint ventures of PSBs lined up for
initial public offering
or divestment in medium to long term, sources said. Wherever required banks should invest funds to scale up operations of their subsidiaries or joint ventures, sources said, adding, banks can look at unlocking value at an opportune time.
As a precursor to monetisation, sources said, banks should improve governance, professional decision-making and bring in greater operational efficiency in their subsidiaries.
For example, the country's biggest lender State Bank of India may look at listing SBI General Insurance and SBI Payment Services in the future after they scale up their operations.
SBI General Insurance Company, incorporated on Feb 24, 2009, earned a profit of Rs 509 crore for the financial year ended March 2025.
The general insurance arm of SBI has allotted 3,71,693 equity shares of Rs 10 each during the year ended March 2025.
Consequently, the stake of SBI in SBI General Insurance Company has reduced from 69.1% to 68.9%.
SBI Payment Services, which is in the merchant acquiring business, is 74% owned by SBI, and the rest with Hitachi Payment Services.
SBI Payments is one of the largest acquirers in the country, with more than 33.1 lakh merchant payment acceptance touch points as of March 31, 2024, including 13.7 lakh POS (point of sales) machines, deployed across geographies. agencies
Stay informed with the latest
business
news, updates on
bank holidays
and
public holidays
.
AI Masterclass for Students. Upskill Young Ones Today!– Join Now
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
30 minutes ago
- Time of India
Big money is making a beeline for Indian hospitals
Indian hospitals are the new goldmine for deep pockets. Besides a rush of investment, a high-intensity consolidation is ongoing in India's hospital space. As per an ET report based on information from sources, IPO-bound Manipal Health Enterprises is leading the race to acquire Sahyadri Hospitals with a Rs 6,838 crore ($800 million) bid. Global investment firm Blackstone is a close second, sources said. IHH Healthcare-backed Fortis Healthcare and EQT Partners also submitted bids on June 23, which was the last day to submit binding financial bids. Also Read: Manipal Health Enterprises leads race to buy Sahyadri Hospitals The Pune-headquartered hospital chain, which operates 11 facilities across Pune, Nashik, Ahilya Nagar and Karad, comprising 1,300 beds, 2,500 clinicians and 3,500 support staff, is owned by Canada's pension fund Ontario Teachers' Pension Plan (OTPP), which had acquired Sahyadri from Everstone Capital in August 2022 at a valuation of around Rs 2,500 crore, outbidding Max Healthcare. Everstone had bought the hospital chain three years earlier in 2019 from its founder, neurosurgeon Charudutt Apte, for about Rs 1,000 crore. The big money chasing Sahyadri for past several years is emblematic of the attraction Indian hospitals, especially smaller chains, have come to hold in recent times. Small-town hospitals are pulling big money Bulge-bracket private equity funds are increasingly investing in single-specialty Indian hospital chains that present a robust growth potential in emerging consuming centers, significantly widening the addressable market beyond their traditional metropolitan bailiwicks, ET had reported in April. Live Events Non-metro locations, such as Lucknow , Vizag, Jaipur, Cochin, Siliguri, Guwahati, Bhubaneswar and Patna, private equity investors believe, hold great growth potential in healthcare, in lockstep with an increasing affordability quotient in tier- 2 or 3 towns, and a greater availability of qualified doctors and specialists. PE funds are looking for players that will give higher returns - and blockbuster exits when the investments run their course. 'A trifecta of factors is helping accelerate investor interest in the single specialty healthcare chains including significant growth opportunity in tier 2/3 cities, clearly visible unit economics and viability with best in class ROIs,' Vishal Bali, executive chairman, Asia Healthcare Holdings (AHH), a leading healthcare investment platform, with focus on single specialities like oncology, women and child care, fertility, urology and nephrology, had told ET. 'AHH has been the inflection point for Single speciality healthcare with all our companies in single speciality healthcare delivering consistent growth in revenues, ebitda and geographical reach along with ROIs' he said. Parking PE monies in treatment areas such as IVF, nephrology, eye-care, oncology, mother & childcare among others, have become a credible prescription for future value creation, after nearly a decade-long hunt for multi-speciality assets across the country. According to an analysis done by Avendus, single-speciality hospitals account for over 40% of all PE investments in healthcare since 2019. This was just a bit over 15% between 2015 and 2018. Between 2020 and early 2025, the segment recorded 24 PE/VC investments totalling $1.8 billion, with 19 of those deals worth $1.2 billion closing in the last two years alone, shows data put together by Grant Thornton. Billions of dollars pour into hospital sector Over the period of two years from 2022-24 Hospitals in India have become one of the preferred investment destination for Investors, attracting net investment of $4.96 billion from Private Equity and $3.2 billion through Foreign Direct Investment (FDI). As per a report prepared by consultancy firm Grant Thornton Bharat in collaboration with the Association of Healthcare providers of India (AHPI), from 2022-24 hospitals in India undertook M&A deals worth $6.74 billion and attracted $4.96 billion from Private Equity (PE) investors. During the period, hospitals also raised $466 million through Initial Public Offering (IPO). The report which analysed 594 M&A and private equity transactions that took place during the period states that, 'Hospitals require diverse funding solutions to sustain growth, ranging from equity financing, debt financing, and foreign direct investment (FDI) to public-private partnerships (PPPs).' As per the investment analysis, the top three investment via PE route includes: Temasek Holdings $2 billion investment in Manipal Health (2023); $656 million by BPEA EQT in Indira IVF (2023); and lastly Blackstone Group $591.1 million investment in Quality Care (2023). A recent big deal was by a New York-based global private-equity and investment company, KKR, which in February bought a controlling stake in leading cancer care hospital chain Healthcare Global (HCG) from private equity peer CVC Capital Partners for nearly $400 million. By acquiring Baby Memorial Hospital last year, KKR made a comeback to the sector after one of its biggest paydays in India exiting Max Healthcare two years ago. Deal-making in India's healthcare sector has surged in recent years, with hospitals now commanding the largest share of foreign direct investment (FDI) within the sector, TOI had reported in December. In FY24, hospitals accounted for 50% of the FDI in total healthcare, translating to $1.5 billion. This marks a significant increase, as the share of hospitals in healthcare FDI has more than doubled from 24% in FY21, and has been rising from 43% in FY20, underscoring their growing prominence. The trend also reflects a strengthening investor preference for hospitals, alongside the traditionally favoured pharmaceuticals sector. The strong private equity interest in India's healthcare services companies is a highly credible indicator of the multi-decade growth potential inherent in the sector, as per a top executive at European investment bank Rothschild & Co. "We expect to see expansion of interest as international players evaluate the market and get more comfortable with the domestic landscape," Hedley Goldberg, partner and global head of healthcare services at Rothschild & Co, told ET in an interview in January. Besides a number of private equity deals, the hospital sector is also attracting big Indian businesses. While several corporates such as Tata , Birla and Hinduja have a presence in healthcare, none has made a significant pan-India presence. But the Bajaj Group is preparing to enter the healthcare sector by setting up a chain of hospitals in metros across the country., ET had reported last year. As per Bloomberg, it has earmarked Rs 10,000 crore as an initial investment. In recent years, healthcare companies and hospitals in India have been increasingly focussing on acquiring buildings and properties to expand their operations and strengthen their market presence. This trend is driven by the rising demand for quality healthcare services in urban and semi-urban areas, fuelled by a growing population, increasing health awareness and better insurance coverage. Hunt for stressed assets In December last year, billionaire Mukesh Ambani's Reliance Industries acquired technology-driven and oncology-focused healthcare platform Karkinos for Rs 375 crore. Reliance bought it under the Insolvency and Bankruptcy Code (IBC). The healthcare sector, particularly hospitals, witnessed major expansion during the Covid-19 pandemic. However, after the situation eased, it became difficult for many standalone hospitals to sustain their businesses. Such hospitals have been seeing interest from two sets of bidders — those already in the industry and seeking to expand and those who want to turn around such entities before they sell to someone else. Promoter-driven strategic investment firms and hospital operators are scouting for stressed healthcare assets that they can acquire through the insolvency and bankruptcy process, as private equity firms often edge them out in the race for good assets by offering lofty valuations. Why India's hospital sector has turned so hot Historically, the pharmaceuticals sector, including APIs (active pharmaceutical ingredients), has been the investor favourite, attracting multi-billion-dollar deals. However, post-Covid, the hospital and diagnostics sector has come into the spotlight, drawing a wave of investors. The Indian hospital sector market cap surged 9x from Rs 37,500 crore in FY20 to Rs 3.5 lakh crore, brokerage firm JM Financial said last year in July. At a time when the sector was grappling with inefficiencies, high leverage and low ROCEs, Covid provided a much-needed impetus. This came from improved pricing, higher insurance coverage and dedicated shift towards complex surgeries such as transplants. India's top listed hospital chains performed well in the stock market leading up to this year. Apollo Hospitals' shares climbed 28% in 2024, while Max Healthcare Institute Ltd. soared 64%. The Indian hospital industry is poised to post a healthy compound annual growth rate (CAGR) of about 12% over the next three fiscal years, credit rating agency CareEdge Ratings said last year. Growing incidence of lifestyle diseases and easing demand for affordable health care delivery are driving the healthcare market in India. A report released last year by HSBC Global Research on India hospitals said seven listed hospitals will add 14,000 beds in the next 3-5 years. A total of 22,000 new beds is expected, including those by other private hospital chains. Even with these additions, there will be no over-supply of beds in India. The report said that the addition of beds is triple the number of beds added between FY19-24 at 4,000. Most hospitals are now in a consolidation phase and planning to expand and add sees growth opportunities after making profits between FY19-24 because of low capex. A World Health Organisation (WHO) report said last year that India has only 16 beds per 10,000 people, which is abysmally low if compared with most of the developed and emerging markets. India requires 100,000 additional beds in the next 5-7 years just to meet its healthcare demand on the back of increasing non-communicable diseases such as diabetes, cardiac disorders, and cancer., as per the HSBC report. The government's push to turn India into a global healthcare hub by promoting medical tourism is another strong growth driver for the hospital sector.
India Today
31 minutes ago
- India Today
BSNL announces flash sale, offers 400GB data for Rs 400 signalling 5G launch is near
BSNL is gearing to launch its commercial 5G services, under the Quantum 5G banner, in India soon. The state-run telco is ramping up capacity by setting up towers and as per the latest news, as many as 90,000 of them are already up and running. To celebrate the milestone, BSNL has announced a limited-time promotional 'flash sale' event where it is giving away 400GB of high-speed 4G data at the rate of Rs 1 per GB. advertisementStarting June 28, BSNL users are eligible to get a new special data recharge pack worth Rs 400 which entitles them to get 400GB of data with a validity of 40 days. The scheme runs through July 1. Since this is a data recharge, users are required to buy it in conjunction with an existing plan. There are no calling or SMS benefits – just 400GB of data. BSNL hints that data will remain unlimited as 'speed reduces to 40 kbps' post 400GB. BSNL recently announced that its 5G services – commercial as well as enterprise – will launch under the name of Quantum 5G or Q-5G. The name was outsourced from the public. As part of the rollout commencement, BSNL unveiled FWA, or fixed wireless access service called Quantum 5G FWA for enterprises in select circles and cities, giving customers access to high-speed connectivity without requiring a SIM card. The telco has been simultaneously running 5G trials for commercial use in Delhi, Jaipur, Lucknow, Chandigarh, Bhopal, Kolkata, Patna, Hyderabad and Chennai. advertisement BSNL 5G is being billed as a next-generation telecom network which is built indigenously from the ground-up. A consortium led by TCS and backed by Tejas Network, C-Dot, and ITI are behind the project with subsequent deployment expected in the next few weeks, if not months. To be able to offer 5G services pan India, BSNL has been doubling down on 4G towers, all of which are also 5G-ready, with the goal of reaching 100,000 soon, thus expediting service deployment and availability. With the flash sale, BSNL clearly wants to build hype and make people excited about the launch of BSNL 5G, which is imminent. With the telco announcing the formal name, the rollout could be any day now, especially given that it was expected to start operations in June 2025. - Ends
NDTV
32 minutes ago
- NDTV
To Sam Altman's "Poaching" OpenAI Talent Charge, Meta CTO's "Dishonest" Reply
Meta has hit back at OpenAI CEO Sam Altman for alleging that the Mark Zuckerberg-led company is offering $100 million compensation packages to poach AI researchers. During an all-hands company meeting last week, Meta CTO Andrew Bosworth debunked Mr Altman's claim that Meta was paying "$100 million signing bonuses" and "more than that" in compensation to recruit OpenAI workers on its AI superintelligence team, according to The Verge. "Sam is just being dishonest here," Mr Bosworth, 43, claimed during the meeting. "He implies we are doing this action for everyone. You see, the market is booming. It's not really hot." Mr Altman recently expressed his happiness that none of OpenAI's "best people" decided to join Meta. During an appearance on the Uncapped podcast last week, Mr Altman further stoked controversy, claiming Meta "started making giant offers to a lot of people on our team." "You know, like $100 million signing bonuses, more than that (in) compensation per year," he claimed. Three leading OpenAI researchers - Xiaohua Zhai, Alexander Kolesnikov, and Lucas Beyer - each denied receiving a $100 million bonus for joining Meta, claiming it was "fake news" on X (formerly Twitter). hey all, couple quick notes: 1) yes, we will be joining Meta. 2) no, we did not get 100M sign-on, that's fake news. Excited about what's ahead though, will share more in due time! cc @__kolesnikov__ and @XiaohuaZhai. — Lucas Beyer (bl16) (@giffmana) June 26, 2025 "Sam is known to exaggerate, and I know exactly why he is doing it, which is because we are succeeding at getting talent from OpenAI," Mr Bosworth said. The ChatGPT creator is engaged in a fierce battle with Meta, the parent company of Facebook and Instagram, to create cutting-edge artificial intelligence. Mark Zuckerberg, 41, has recently intensified his efforts to develop superintelligence-AI that is more intelligent than humans in terms of knowledge, memory, and reasoning. The company reportedly invested $14.3 billion in Scale AI and established a new AI lab aimed at obtaining "superintelligence." Meta has acquired the services of former GitHub CEO Nat Friedman and Daniel Gross, the CEO of Safe Superintelligence, a $32 billion AI business. Trapit Bansal, a key AI researcher who has worked with OpenAI since 2022 and helped develop the company's initial AI reasoning model, reportedly departed the company for Meta on Thursday, according to TechCrunch.
